Armistice Capital’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $152M | Sell |
|
|||||
|
2025
Q1 | $170M | Buy |
|
|||||
|
2024
Q4 | $175M | Sell |
|
|||||
|
2024
Q3 | $159M | Sell |
|
|||||
|
2024
Q2 | $141M | Buy |
|
|||||
|
2024
Q1 | $122M | Sell |
|
|||||
|
2023
Q4 | $135M | Sell |
|
|||||
|
2023
Q3 | $140M | Buy |
|
|||||
|
2023
Q2 | $151M | Buy |
|
|||||
|
2023
Q1 | $158M | Sell |
|
|||||
|
2022
Q4 | $155M | Sell |
|
|||||
|
2022
Q3 | $155M | Sell |
|
|||||
|
2022
Q2 | $136K | Buy |
|
|||||
|
2022
Q1 | $100M | Sell |
|
|||||
|
2021
Q4 | $121M | Buy |
|
|||||
|
2021
Q3 | $104M | Buy |
|
|||||
|
2021
Q2 | $102M | Sell |
|
|||||
|
2021
Q1 | $89.3M | Buy |
|
|||||
|
2020
Q4 | $78.5M | Sell |
|
|||||
|
2020
Q3 | $66.7M | Buy |
|
|||||
|
2020
Q2 | $52.4M | Sell |
|
|||||
|
2020
Q1 | $54M | Buy |
|
|||||
|
2019
Q4 | $40.6M | Buy |
|